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Reviewing Colchicaceae Alkaloids – Perspectives of Evolution on Medicinal 
Chemistry 
Sonny Larsson* and Nina Rønsted 
Botanic Garden, Natural History Museum of Denmark, Sølvgade 83, Opg. S, Copenhagen DK-1307, Denmark 
Abstract: The subject of chemosystematics has provided insight to both botanical classification and drug development. 
However, degrees of subjectivity in botanical classifications and limited understanding of the evolution of chemical char-
acters and their biosynthetic pathways has often hampered such studies. In this review an approach of taking phylogenetic 
classification into account in evaluating colchicine and related phenethylisoquinoline alkaloids from the family Colchi-
caceae will be applied. Following on the trends of utilizing evolutionary reasoning in inferring mechanisms in eg. drug re-
sistance in cancer and infections, this will exemplify how thinking about evolution can influence selection of plant mate-
rial in drug lead discovery, and how knowledge about phylogenetic relationships may be used to evaluate predicted bio-
synthetic pathways. 
Keywords: Alkaloids, biosynthetic pathways, colchicaceae, colchicine, evolution, phylogenetic prediction. 
INTRODUCTION 
Using chemical information to define groups of plants is 
probably as old as botanical classification itself, a practice 
often referred to as chemosystematics or chemotaxonomy. In 
the modern sense it was largely introduced during the 1960s 
and 1970s, for example with the works of Bate-Smith [1,2], 
Swain [3] and Harborne [4], and by the founding of the jour-
nal now known as Biochemical Systematics and Ecology in 
1973. In 1980 Dahlgren published the first systematic classi-
fication for flowering plants emphasizing chemical charac-
ters in defining relationships between families and higher 
taxa [5], visualizing the distribution of characters in the ear-
lier introduced form of dahlgrenograms [6]. With the advent 
of molecular systematics based on comparison of nucleotide 
sequences, several of the groups which were previously to 
some extent defined by chemical characters, received even 
further support: the close relationships of the families con-
taining betalain pigments instead of anthocyanins in Caryo-
phyllales [7]; the occurrence of benzylisoquinoline alkaloids 
in the families of Dahlgren’s Magnoliflorae [8]; the “mustard 
oil bomb” of the order Brassicales [9]; and the iridoids in the 
asterids [10]. The collective literature has thus confirmed the 
statement of Helen Abbott in 1887 that “the evolution of 
chemical constituents follows parallel lines with the evolu-
tionary course of plant forms, the one being intimately con-
nected with the other…” [11]. 
Natural products have been hitherto a very successful 
source of new drugs, with slightly more than a third of 
“small compounds” launched as “new chemical entities” for 
the past 30 years belonging to this group [12]. At the same 
time it has been shown that natural products occupy  
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a different and larger chemical space than synthetic drugs 
[13, 14, 15], and that they have a higher probability to pass 
through the pharmaceutical industry drug developmental 
pipeline [16]. This is today usually discussed within the con-
cept of natural products being prevalidated for activity [14, 
15, 17, 18, 19, 20, 21]. As these compounds per definition 
are derived within a biological setting they are today pre-
sumed to have some sort of function or raison d’être, and 
even if this function is unknown, unstudied or only based on 
available bioassays, it is clear that this inherent property is 
influenced by evolution [22, 23]. Following on the trends of 
utilizing evolutionary reasoning in inferring mechanisms in 
eg. drug resistance in cancer and infections, this contribution 
will exemplify how thinking about evolution can influence 
selection of plant material for drug lead discovery, and how 
knowledge about phylogenetic relationships may be used to 
evaluate predicted biosynthetic pathways. As a case in point, 
an approach of taking phylogenetic classification into ac-
count in evaluating the medicinally important and histori-
cally fascinating alkaloid colchicine and related phenethyli-
soquinoline alkaloids from the family Colchicaceae is ap-
plied. 
DISCOVERY AND MEDICINAL USE OF COLCHI-
CINE 
Colchicine, present in and named after the autumn crocus 
(Colchicum autumnale L., Colchicaceae), is today a well-
known compound recognized for its antimitotic activity and 
as a treatment for acute gout and familial Mediterranean fe-
ver, a hereditary inflammatory disorder [24, 25, 26]. But the 
history of colchicine is full of misunderstandings and ill-
advised inferences. This drug has truly ancient origins, being 
present in the writings of several classical Greek physicians 
from Nicander of Colophon, over Dioscorides, Pliny the 
Elder and Galen, to Alexander of Tralles [27]. Its use as a 
medication was however heavily discouraged by its toxicity, 
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and often it was described rather as a poison than a remedy. 
The true identification was also heavily debated and views 
on whether terms such as colchicon, ephemeron, hermodac-
tylum and surugen were equivalent differed between scholars 
at various times in history. Autumn crocus corm was present 
in the London Pharmacopoeia between 1618 and 1639, after 
which it was not mentioned until the 1788 edition [28]. The 
modern introduction of colchicine-based medicines for gout 
is usually attributed to von Störck in 1763 [29], but see Har-
tung [27] for counter-arguments. Colchicine-based medi-
cines have been continuously employed as a remedy for this 
condition since the very early 19th century. The use of col-
chicine has been based on clinical experience, and it was 
only in 2009 the U. S. Food and Drug Administration ap-
proved it based on clinical trials defining dosage and effi-
cacy [30]. 
Colchicine was identified as a “mitotic poison” in the 
early 1930s and its use in production of polyploid plants was 
described in 1937 [31]. It was used in the determination of 
the chromosome number for the human species [32], and has 
since the explanation of its tubulin-interaction been an im-
portant tool in biochemistry and development of cancer 
drugs [26, 33, 34]. Colchicine itself is too toxic to be used as 
a treatment for cancer, but other alkaloids and derivatives 
have been investigated. One of the first examples is the use 
of the alkaloid demecolcine, a deacetylated and methylated 
derivative against myeloid leukemia [35], and recently the 
allocolchinoid phosphate-derivative ZD6126 has been stud-
ied [34]. 
Just as the medicinal use has a complicated history, this 
is equally true for the alkaloid itself. The first colchicine 
isolation is usually considered to be by Pelletier and Caven-
tou in 1820 [36]. However, they considered the isolated 
compound to be the alkaloid veratrine, a steroid-derived al-
kaloid from plants in the death camas family Melanthiaceae, 
and Geiger was the first to coin the name colchicine after 
crystallization of the pure compound in 1833 [37]. The struc-
ture of the alkaloid proved to be very elusive, and it was not 
elucidated until the x-ray crystallography investigation of 
King and co-workers in 1952 [38], confirming the supposi-
tion of Dewar that the compound contain two 7-membered 
rings of which one is a tropolone [39]. A review of synthetic 
approaches to colchicine was published in 2004 [40].  
BIOLOGICAL ORIGIN 
Colchicine is considered to have a restricted distribution 
within the plant kingdom [41, 42], and is isolated commer-
cially from the related ornamental species autumn crocus 
(Colchicum autumnale L.) and flame lily (Gloriosa superba 
L.). The medicinal importance of colchicine prompted early 
screenings of the plant kingdom to find suitable sources for 
the compound. From these early reviews a much wider dis-
tribution for colchicine was inferred [43]. However, refined 
chemical detection methods have discarded many reports as 
false positives [41, 44]. The more restricted distribution 
originally proposed coincided largely with the, at that time, 
recently introduced lilioid subfamily Wurmbaeoideae [45], 
today more familiar as the family Colchicaceae [46].  
With the advent of molecular systematics based on com-
parison of DNA sequences it was shown that a few genera 
(such as Disporum Salisb., Uvularia L., Kuntheria Conran & 
Clifford, Schelhammera R.Br., and Tripladenia D.Don) pre-
viously placed in other families should be included in an 
expanded Colchicaceae family and a new classification has 
been adopted, (see Table 1) [47, 48]. Investigation of crude 
alkaloid extracts with mass spectrometry has also confirmed 
that colchicine is present in, and restricted to, the genera of 
Colchicaceae in this wider circumscription [49].  
 
Table 1. Classification of the Family Colchicaceae [47], In-
cluding Selected Generic Synonyms Present in the 
Chemical Literature. 
Tribe Genus Synonyms 
Burchardieae Burchardia R.Br.  
Disporum Salisb.  
Uvularieae 
Uvularia L.  
Kuntheria Conran & 
Clifford 
 
Schelhammera R.Br.  
Tripladenieae 
Tripladenia D.Don  
Camptorrhiza E.Phillips Iphigeniopsis Buxb. 
Iphigenieae 
Iphigenia Kunth  
Baeometra Salisb.  
ex Endl. 
 
Anguillarieae 
Wurmbea Thunb. 
Anguillaria R.Br. 
Dipidax Lawson  
ex Salisb. 
Neodregea C.H.Wright 
Onixotis Raf. 
Colchicum L. 
Androcymbium Willd. 
Bulbocodium L. 
Merendera Ramond 
Gloriosa L. Littonia Hook. 
Hexacyrtis Dinter  
Ornithoglossum Salisb.  
Colchiceae 
Sandersonia Hook.  
 
An Australian species described under the name Krey-
sigia multiflora Rchb. has been shown to contain colchicine 
and other alkaloids [50]. However the exact identity of this 
species is confounded by the application of this name to 
plants belonging to Schelhammera as well as Tripladenia.  
Just as genera have been included in the family based on 
phylogenetic analysis of nucleotide data, analysis of such 
data has also resulted in a notable exclusion. The genus Dis-
porum was considered to be present in both Asia and North 
America, but results from genetic studies have shown that 
the North American representatives should be treated as a 
distinct genus, Prosartes D.Don, and be moved to the family 
Liliaceae [51]. The family Colchicaceae as currently circum-
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scribed thus constitutes 15 genera and about 280 species, of 
which more than half belong to Colchicum [48]. 
ALKALOID DIVERSITY 
A number of reviews on phenethylisoquinoline alkaloids 
can be found in the literature [eg. 52]. However, they usually 
only treat a particular group of a specific structural type and 
will be exemplified under the respective alkaloid type below. 
The present contribution provides a review of Colchicaceae 
alkaloids of all types as well as perspectives of their origin, 
evolution and hypothetical biosynthetic pathways. 
In the Combined Chemical Dictionary [53] there are 
about 150 entries with structurally elucidated alkaloids re-
ported from Colchicaceae genera. They are biosynthetically 
derived from condensation of phenylalanine and tyrosine to a 
phenethylisoquinoline precursor, which has been shown by 
several feeding experiments in elucidation of colchicine bio-
synthesis [54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65]. 
Based on proposed biosynthesis, feeding experiments and 
analogies of pathways elucidated for benzylisoquinoline al-
kaloids, as presented in Fig. (1), we discern eight distinct 
structural types of alkaloids in the family Colchicaceae: 
phenethylisoquinolines, homoproaporphines, homoapor-
phines, androcymbines (homomorphinans), colchicines, al-
locolchicines, lumicolchicines and homoerythrinans. 
Phenethylisoquinolines and homoerythrinans have also been 
isolated from Dysoxylum in the mahogany family Meliaceae, 
which also contain a dibenzo[d,f]azecine alkaloid [53, 66, 
67, 68, 69]. The homoerythrinan alkaloids also have addi-
tional disjunct occurrences in the monogeneric New Caledo-
nian family Phellinaceae [53, 70] and the gymnosperm fami-
lies Taxodiaceae, Podocarpaceae and Cephalotaxaceae [53, 
71, 72]. Another group of alkaloids derived from phenethyli-
soquinoline precursors are the cephalotaxines unique for the 
family Cephalotaxaceae, which has recently been reviewed 
[73]. Thus, in total there are ten structural types of alkaloids 
with a possible common precursor. The hypothetical network 
of their interrelations as presented in Fig. (1), builds on pos-
sible transformations known to occur in biochemical reac-
tions and transforming one structural type into another. The 
included diaryl-3-azahexanoid precursors could constitute 
alternative biosynthetic pathways to homoerythrinan alka-
loids explaining their disjunct distribution.  
Phenethylisoquinolines (Type A) 
Six phenethylisoquinoline alkaloids have been described 
from Colchicaceae, see Fig. (2), of which autumnaline is 
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Fig. (1). Hypothetical network of phenethylisoquinoline derived alkaloids based on proposed biosynthesis, feeding experiments and analo-
gies of pathways elucidated for benzylisoquinoline alkaloids. A: phenethylisoquinolines; B: homoproaporphines; C: homoaporphines; D: 
androcymbines; E: colchicines; F: allocolchicines; G: lumicolchicines; H: dibenzo[d,f]azecines; I: homoerythrinans; and J: cephalotaxines. 
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proposed as a key intermediate. There are only few reports of 
isolation of these alkaloids [74, 75, 76, 77, 78], perhaps due 
to their proposed functions as precursors and thus efficient 
transformation into other structural types. They do not seem 
to have been tested for biological activity, but phenethyliso-
quinolines from Dysoxylum have shown effects on isolated 
rat cardiac muscle [79]. 
 
N
H
Me
R2
R1
R3
R4
R5  
 R1 R2 R3 R4 R5 H 
autumnaline OH OMe OH OMe OMe ? 
isoautumnaline OMe OH OH OMe OMe ? 
colchiethanamine OMe OH H OH H ? 
colchiethine OMe OH H OMe H ? 
 
N Me
OMe
HO
O
N Me
OMe
OH
 
jolantinine 
N Me
OMe
O
OH
O
N
OH
Me
MeO
H
H
 
melanthioidine 
Fig. (2). Structural diversity of the phenethylisoquinoline alkaloids 
in Colchicaceae. 
 
Homoproaporphines (Type B) 
These minor alkaloids, see Fig. (3), have been isolated 
primarily from the Eurasian species of Colchicum [80, 81, 
82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96], but 
are also present in African [97] and Australian taxa [98]. 
Several homoproaporphines have been investigated for cho-
linergic activity [99, 100], showing moderate anticho-
linesterase activities. 
Homoaporphines (Type C) 
These alkaloids were last reviewed in 1989, see Fig. (4), 
[101], and very few have been investigated for biological 
activity [100]. 
Androcymbines (Type D) 
This group, see Fig. (5), is sometimes called homomor-
phinandienones. The isolation and structure elucidation of 
androcymbine and O-methylandrocymbine proved to be es-
sential for understanding the biosynthetic origin of colchi-
cine, finally linking this “alkaloid sui generis” to the 
phenethylisoquinoline precursors [74, 102].  
Colchicines (Type E) 
This is the largest group of alkaloids within Colchicaceae 
as of today, see Fig. (6). A statement that is true even if, as 
done here, the allo- and lumicolchicine derivatives are ex-
cluded. They commonly interact with tubulin and are con-
sidered to be a main toxic principle of Colchicaceae plants. 
They have also been evaluated for anticholinesterase activity 
[103]. This is the first isolated group of alkaloids containing 
a tropolone ring in their structure, a fact that has been used to 
distinguish them from other alkaloids in simple TLC screen-
ings due to a positive Oberlin-Zeisel reaction when sprayed 
with FeCl3 after treatment with HCl vapor [41], and are thus 
sometimes known as tropolonic alkaloids. This name would 
however also include the unrelated tropoloisoquinoline alka-
loids described from Abuta in the moonseed family Menis-
permaceae [104, 105, 106]. Colchicines were reviewed by 
Boyé and Brossi in 1992 [107], and have not been updated 
since. A further ten colchicine-type alkaloids have been de-
scribed as minor components from Colchicum and Gloriosa 
species since that review [78, 108, 109, 110, 111]. Even 
though colchicine itself is deemed to be too toxic as an anti-
cancer drug, investigation of compounds binding to the same 
site and interacting with tubulin is an active field of research 
[112]. There is also a continued interest in modification of 
the colchicine-type core to modify toxicity and activity of 
these compounds [113, 114, 115, 116]. 
Allocolchicines (Type F) 
These alkaloids are also called dibenzocyclohepty-
lamines, see Fig. (7), and have been suggested to be cata-
bolic metabolites of colchicines [117, 118]. They usually 
retain the colchicine-type alkaloids ability to bind to tubulin 
but are less toxic, which has yielded some interest as poten-
tial antitumor drugs [34, 119]. 
Lumicolchicines (Type G) 
There is a debate whether these alkaloids, see Fig. (8), 
are produced in the plant or simply artifacts from the isola-
tion since they can also be formed as photoisomers from 
colchicine-type alkaloids under influence by light. In con-
trast to allocolchicines the lumicolchicine-derivatives lack 
specific binding to tubulin. 
Homoerythrinans (Type I) 
This group of alkaloids has a very narrow distribution 
within Colchicaceae and has only been found in the Austra-
lian genera Schelhammera and Kuntheria [120, 121, 122, 
123, 124], of which the latter is a relatively recent taxonomic 
split from the former [125]. However, among the phenethyli-
soquinoline alkaloids this is a very widespread group present 
in Dysoxylum of Meliaceae [66], Phelline of Phellinaceae 
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R2 R1
R5
R4
H
a
b
 
 R1 R2 R3 R4 R5 H a b 
bulbocodine Me OH OMe =O H ? double single 
jolantamine Me OH OMe =O H ? double single 
jolantine Me2 (+) OH OMe =O H ? double single 
crociflorinone Me OMe OMe =O H ? double single 
kreysiginone Me OH OMe =O OMe ? double double 
dihydrokreysiginone Me OH OMe =O OMe ? single double 
luteidine Me OH OMe =O OMe ? single double 
luteidine N?-oxide Me, O OH OMe =O OMe ? single double 
luteidine N?-oxide Me, O OH OMe =O OMe ? single double 
trigamine Me OH OMe OH H ? single single 
trigamine N-oxide Me, O OH OMe OH H ? single single 
NH
OMe
HO
O O                                   
N
R2
O
R3
R4
R1
H
 
 jolantimine 
 R1 R2 R3 R4 H 
kesselridine Me OH OH (?) OH (?) ? 
regelamine Me OMe OH (?) OH (?) ? 
jolantidine H OMe OH (?) OH (?) ? 
kesselringine Me OH OH (?) OMe (?) ? 
regeline Me OMe OH (?) OMe (?) ? 
luteine Me OH OH (?) OMe (?) ? 
regelinine Me OMe OH (?) OMe (?) ? 
regecoline Me (+) O (–) OH (?) OMe (?) N-double 
isoregecoline Me (+) O (–) OH (?) OMe (?) N-double 
robustamine Me OMe OH (?) OMe (?) ? 
robustamine N?-oxide Me, O OMe OH (?) OMe (?) ? 
N+
-O
O
HO
OMe
Me
O
                                         
N
R1
O
Me
R3
R2
R4
 
  regelinone (?-form)                                    isoregelinone (?-form) 
 R1 R2 R3 R4 
colchilutine OMe H H =O 
luteicine OMe OH OMe H 
Fig. (3). Structural diversity of the homoproaporphine alkaloids in Colchicaceae. 
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R3
R2
R5
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H
 
 R1 R2 R3 R4 R5 R6 H 
alkaloid CC24 Me OH OMe OMe OMe OH ? 
multifloramine, (–)-form Me OH OMe OMe OH OMe ? 
floramultine Me OH OMe OH OMe OMe ? 
kreysigine, (–)-form Me OH OMe OMe OMe OMe ? 
baytopine Me OMe OMe OH OMe OH ? 
merobustinine Me OMe OH OMe OH OMe ? 
androbine Me OMe OH OH OMe OMe ? 
norandrobine H OMe OH OH OMe OMe ? 
merobustine Me OH OMe OMe OMe OH ? 
multifloramine, (+)-form Me OH OMe OMe OH OMe ? 
merenderine Me OH OMe OH OMe OMe ? 
merenderine N-oxide Me, O OH OMe OH OMe OMe ? 
szovitsamine Me OMe OMe OMe OMe OH ? 
szovitsamine N?-oxide Me, O OMe OMe OMe OMe OH ? 
androcimine Me OMe OMe OH OMe OMe ? 
androcine Me OMe OH OMe OMe OMe ? 
kreysigine, (+)-form Me OH OMe OMe OMe OMe ? 
kreysigine N?-oxide Me, O OH OMe OMe OMe OMe ? 
O-methylkreysigine Me OMe OMe OMe OMe OMe ? 
O-methylkreysigine N-oxide Me, O OMe OMe OMe OMe OMe ? 
nor-O-methylkreysigine H OMe OMe OMe OMe OMe ? 
szovitsinine Me OMe OH OMe OMe OH ? 
N-methylmerenderine Me2 (+) OH OMe OH OMe OMe ? 
Fig. (4). Structural diversity of the homoaporphine alkaloids in Colchicaceae. 
 
N
R1
R5
R6
R2
R3
R4
a
 
 R1 R2 R3 R4 R5 R6 a ethano-bridge 
alkaloid CC-2 Me OMe –OCH2O– OH (?) OMe (?) single ? 
alkaloid CC-20 Me OMe –OCH2O– =O OMe double ? 
alkaloid CC-3b Me OMe OMe OH OH (?) OMe (?) single ? 
androcymbine Me OMe OH OMe =O OMe double ? 
O-methyl-androcymbine Me OMe OMe OMe =O OMe double ? 
isoandrocymbine Me OMe OMe OH =O OMe double ? 
collutine Me OH OMe OMe =O OMe double ? 
collutine N-oxide Me, O OH OMe OMe =O OMe double ? 
alkaloid CC-10 Me OMe OMe OH =O OMe double ? 
szovitsidine Me OMe OMe OMe OH (?) OMe double ? 
colchiritchine H OMe –OCH2O– =O OMe double ? 
N Me
OH
OMe
O
OMe
OMe
 (±)-kreysiginine 
Fig. (5). Structural diversity of the androcymbine (homomorphinan) alkaloids in Colchicaceae. 
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R1
R3
R4
R5
O
R2
 
 R1 R2 R3 R4 R5 
colchicine NHAc OMe OMe OMe OMe 
colchifoline NH(AcOH) OMe OMe OMe OMe 
2-demethyl-colchifoline NH(AcOH) OMe OH OMe OMe 
N-deacetyl-colchicine NH2 OMe OMe OMe OMe 
gloriosine a) NHCHO OMe OMe OMe OMe 
N-deacetyl-N-(3-oxobutyryl)-colchicine NH(AcAc) OMe OMe OMe OMe 
demecolcine b) NHMe OMe OMe OMe OMe 
N-formyldemecolcine NMeCHO OMe OMe OMe OMe 
N-ethoxycarbonyl-colchicine NH(COOEt) OMe OMe OMe OMe 
N-methyldemecolcine NMe2 OMe OMe OMe OMe 
2-demethylgloriosine NHCHO OMe OH OMe OMe 
2-demethylcolchicine NHAc OMe OH OMe OMe 
2-demethyldemecolcine NHMe OMe OH OMe OMe 
N-deacetyl-3-demethylcolchicine c) NH2 OMe OMe OH OMe 
1'-epicolchicoside NHAc OMe OMe O-?-D-glc OMe 
colchicoside NHAc OMe OMe O-?-D-glc OMe 
3-demethylgloriosine NHCHO OMe OMe OH OMe 
3-demethylcolchicine NHAc OMe OMe OH OMe 
3-demethyldemecolcine NHMe OMe OMe OH OMe 
3-demethyl-N-methyldemecolcine NMe2 OMe OMe OH OMe 
deacetylcolchiceine NH2 OMe OMe OMe OH 
glorioseine d) NHCHO OMe OMe OMe OH 
colchiceine NHAc OMe OMe OMe OH 
demecolceine e) NHMe OMe OMe OMe OH 
1,2-didemethylcolchicine NHAc OH OH OMe OMe 
N-deacetyl-2,3-didemethylcolchicine NH2 OMe OH OH OMe 
2,3-didemethylcolchicine NHAc OMe OH OH OMe 
2,3-didemethyldemecolcine NHMe OMe OH OH OMe 
2-demethylcolchiceine NHAc OMe OH OMe OH 
3-demethylcolchiceine NHAc OMe OMe OH OH 
speciosine NMe(2-OH-benzyl) OMe OMe OMe OMe 
O-methylspeciosine NMe(2-OMe-benzyl) OMe OMe OMe OMe 
speciocolchine NMe(2-OH-benzyl) OMe OH OMe OMe 
specioritchine NMe(2-OH-benzyl) OMe OMe OH OMe 
specioseine NMe(2-OH-benzyl) OMe OMe OMe OH 
speciosamine NMe(benzyl) OMe OMe OMe OMe 
a) N-deacetyl-N-formylcolchicine; b) colchamine; c) substance U; d) N-deacetyl-N-formylcolchiceine; e) colchameine 
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(Fig. 6) contd…. 
R1
R3
R4
R5
O
R2
OH
 
 R1 R2 R3 R4 R5 
colchiciline NHAc OMe OMe OMe OMe 
alkaloid CC12 (isomeric) NHAc OMe OMe OMe OMe 
2-demethylcolchiciline NHAc OMe OH OMe OMe 
gloriosamine C NH(AcOH) OMe OMe OMe OMe 
gloriosamine D NHCHO OMe OMe OMe OMe 
R1
R3
O
R2
O
O
R4
 
 R1 R2 R3 R4 
cornigerine NHAc OMe OMe H 
N-deacetyl-N,N-dimethyl-cornigerine NMe2 OMe OMe H 
gloriosamine A NHAc OMe OMe OMe 
gloriosamine B NH(AcOH) OMe OMe OMe 
Fig. (6). Structural diversity of the colchicine-type alkaloids in Colchicaceae. 
 
R1
R2
R3
R4
R5
R6
R7
 
 R1 R2 R3 R4 R5 R6 R7 
2-demethyl-allocolchicine NHAc OMe OMe OH H COOMe H 
allocolchicine a) NHAc OMe OMe OMe H COOMe H 
colchibiphenyline NHAc OMe OMe OH H OMe OH 
androbiphenyline NHAc OMe OMe OMe H OMe OH 
jerusalemine NHMe OMe OH OMe OH OMe H 
salimine NHAc OMe OMe OMe COOMe OH H 
Fig. (7). Structural diversity of the allocolchicine alkaloids in Colchicaceae. a) suhailamine may be an isomer of allocolchicine and not a 
synonym of that compound. 
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R1
R2
R3
R4
R5
O
H
H
 
 R1 R2 R3 R4 R5 H 
?-lumicolchicine NHAc OMe OMe OMe OMe ?, ? 
?-lumigloriosine a) NHCHO OMe OMe OMe OMe ?, ? 
N-deacetyl-N,N-dimethyl-?-lumicolchicine NMe2 OMe OMe OMe OMe ?, ? 
?-lumispeciosine NMe(2-OH-benzyl) OMe OMe OMe OMe ?, ? 
N-methyl-?-lumicolchicine NMeAc OMe OMe OMe OMe ?, ? 
2-O-demethyl-?-lumicolchicine NHAc OMe OH OMe OMe ?, ? 
3-O-demethyl-?-lumicolchicine NHAc OMe OMe OH OMe ?, ? 
2-O-demethyl-?-lumigloriosine NHCHO OMe OH OMe OMe ?, ? 
?-lumicolchicine NHAc OMe OMe OMe OMe ?, ? 
?-lumigloriosine b) NHCHO OMe OMe OMe OMe ?, ? 
2-O-demethyl-?-lumicolchicine NHAc OMe OH OMe OMe ?, ? 
3-O-demethyl-?-lumicolchicine NHAc OMe OMe OH OMe ?, ? 
Colchicum autumnale alkaloid M NMeAc OMe O-?-D-glc OMe OMe ?, ? 
a) N-deacetyl-N-formyl-?-lumicolchicine; b) N-deacetyl-N-formyl-?-lumicolchicine 
MeO
MeO
OMe
OMe
OMe
MeO
OO
H
H
MeO
H
NHAcAcHN
MeO
H
H
H
                           
O
O
O
MeO
MeO
H
H
Me2N
 
         ?-lumicolchicine                                                  alkaloid AM3 
Fig. (8). Structural diversity of the lumicolchicine alkaloids in Colchicaceae. 
 
[70], Athrotaxis of Taxodiaceae [71], Manoao of Podocar-
paceae [72], and Cephalotaxus of Cephalotaxaceae [73]. 
Some homoerythrinan alkaloids can even be found in several 
of these families, eg. taxodine and 3-epischelhammericine. 
The ten homoerythrinan-type alkaloids found in Colchi-
caceae, see Fig. (9), have not been studied for biological 
activity in any great detail. The alkaloid 3-
epischelhammericine as well as other alkaloids from Dysoxy-
lum have shown molluscicidal activity and cardiac effects 
[67, 79], and dyshomoerythrine from Manoao is reported to 
have insecticidal activity [126]. 
Miscellaneous Alkaloids 
Five alkaloids, see Fig. (10), reported from Colchicaceae 
have structures not completely consistent with any of the 
previous groups. They are all isolated from different species 
of Colchicum [110, 127, 128, 129].  
Phylogeny of Colchicaceae and Alkaloid Distribution 
A phylogenetic hypothesis of plant relationships is de-
pendent on sampling size, which is a function of the number 
of investigated plant species and the number of characters in 
the matrix. In molecular systematic studies based on nuclear 
sequences the characters will equal the number of nucleo-
tides in the sequence used for analysis. For Colchicaceae a 
family wide investigation based on chloroplast gene se-
quences, representing fourteen out of fifteen genera (the sin-
gle species of Kuntheria was not sampled) has been pub-
lished [47]. A genus-level tree based on those results, with 
Kuntheria placed together with Schelhammera and Triplade-
nia, is shown in Fig. (11). 
Chemosystematic prediction is likewise dependent on 
sampling size, here as a function of the number of investi-
gated plant species and the limits of detection for the 
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N
R4
R3
R1
R2
a
b
c
 
 R1 R2 R3 R4 a b c 
taxodine OH OMe OMe (?) H single double single 
3-epicomosine –OCH2O– OMe (?) H double singles, H (?) 
schelhammerine –OCH2O– OMe (?) OH (?) single double single 
schelhammericine –OCH2O– OMe (?) H single double single 
3-epischelhammerine –OCH2O– OMe (?) OH (?) single double single 
3-epischelhammericine –OCH2O– OMe (?) H single double single 
schelhammeridine –OCH2O– OMe (?) H double single double 
3-epischelhammeridine –OCH2O– OMe (?) H double single double 
N
OMe
O
O
O
                                 
N
OMe
O
O
O
 
8-oxoschelhammeridine                                           11a-oxoschelhammeridine 
Fig. (9). Structural diversity of the homoerythrinan alkaloids in Colchicaceae. 
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MeO
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N
MeO
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Me
 
demecolcinone 
OMe
MeO
OMe
O
MeO
O
NHAc
 
10,11-oxy-10,12a-cyclo-10,11-
secocolchicine 
N
O
HO
OMe
Me
 
luteinine 
MeO
OMe
OMe
OMe
O
N Me
 
crociflorinine, with crociflorine 
being its N-oxide 
Fig. (10). Structural diversity of miscellaneous phenethylisoquinoline alkaloids in Colchicaceae. 
 
compounds of interest using a specific method. As the 
Colchicaceae alkaloids span from alkaline compounds, over 
aprotic or quaternary nitrogen compounds insensitive to pH-
changes, to phenolic alkaloids even within the different 
structural types the isolation method may bias the detection 
of compounds [130]. Another bias in reviewing Colchi-
caceae alkaloids may be the strong focus on detection of 
colchicine itself in the literature. This alkaloid is by far the 
most commonly reported compound, and it has been shown 
to be present in all investigated genera of the family by 
nanospray-MS (again with the single species of Kuntheria 
unsampled) [49]. 
However, the similarities between the systematic and 
chemical sampling on genus level makes Colchicaceae a 
good case study in evolution of chemical characters. The 
genera Uvularia and Disporum have been treated as part of 
the now defunct family Uvulariaceae, which by some 
authors also have included Schelhammera (including the 
later segregated Kuntheria) and Tripladenia, though these 
latter genera have also been placed in the former Conval-
lariaceae [46, 131]. Burchardia has been reported to be de-
void of tropolonic alkaloids [132], and its relationship to the 
rest of Colchicaceae have been questioned and sometimes it 
is instead treated in a monogeneric family Burchardiaceae 
[133]. The alkaloid chemistry of the early diverging lineages, 
Burchardieae and Uvularieae, has not been investigated in 
any detail according to standard literature searches, but the 
three genera are confirmed to contain colchicine [49].  
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Fig. (11). The phylogenetic hypothesis and classification for Colchicaceae modified from Vinnersten and co-workers [46, 47]. The dendro-
gram clearly shows that the groups not traditionally associated with phenethylisoquinoline alkaloids constitute the basal clades of the family. 
As further discussed in the text this highlights them as potential new sources of Colchicaceae alkaloids, or even new structural types of 
phenethylisoquinoline alkaloids.  
 
The chemistry of the tribe Tripladenieae, which is re-
stricted to eastern Australia extending to New Guinea, have 
in comparison been fairly extensively investigated. The gen-
era Schelhammera and Kuntheria are unique in Colchicaceae 
by producing homoerythrinan instead of colchicine-type al-
kaloids as major components [120, 121, 122, 123, 124]. Fur-
ther investigations are needed to see if this is the case for 
Tripladenia as well. However, as stated above a plant under 
the name of Kreysigia multiflora has been shown to contain 
appreciable amount of homoaporphine, homoproaporphine 
and colchicine-type alkaloids [50, 134, 135], and this plant is 
either Tripladenia or a species of Schelhammera. The collec-
tion data for the material used by Badger and Bradbury [134] 
indicate that their original isolation is done on Tripladenia 
cunninghamii. Our nanospray mass spectrometry screening 
has confirmed the presence of colchicine in both Schelham-
mera and Tripladenia [49]. 
The three remaining tribes constitute the classical sub-
family Wurmbaeoideae [45] or Colchicaceae in its strict 
sense [46] and several reviews of their alkaloid contents have 
been published [41, 44, 52, 107, 136]. Besides colchicine- 
and lumicolchicine-type alkaloids Iphigenieae also contain 
homoaporphine and homomorphine alkaloids [101, 137, 138, 
139], while only colchicine- and lumicolchicine-type alka-
loids have been reported from the few species investigated 
from the tribe Anguillarieae [44, 132]. The most species-rich 
tribe is Colchiceae, which also contains Colchicum and Glo-
riosa the two most studied genera, and it is reported to con-
tain all structural types present in Colchicaceae except for 
homoerythrinan alkaloids [97, 101, 108, 109, 111, 117, 140, 
141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 
153, 154, 155, 156]. 
Presence of Pathways 
Combining this distribution data with the hypothetical 
biosynthetic network in Fig. (1) indicates that the pathway to 
colchicine-type alkaloid is present in all genera of Colchi-
caceae. Since this pathway contains the androcymbine-type 
alkaloids as an intermediate, these are also expected to have 
a family-wide distribution. The homoaporphine and homo-
proaporphine alkaloids are both present in the tribe Col-
chiceae, while only homoaporphines are present in the tribe 
Iphigenieae. This could indicate that the two types are bio-
synthesized by independent pathways, and that homo-
proaporphines are not precursors for homoaporphines as 
would be suggested by analogy with benzylisoquinoline al-
kaloids. There is some experimental evidence that this is the 
case [57]. 
The homoerythrinan alkaloids are often discussed to-
gether with their erythrinan counterparts [157, 158, 159], and 
their biosynthesis is considered to be analogous to these. The 
two possible pathways to homoerythrinan alkaloids in Fig. 
(1) could explain the disjunct distributions of these alkaloids 
without co-occurrence of androcymbine- or colchicine-type 
alkaloids outside Colchicaceae. A pathway analogous to that 
proposed for erythrinan alkaloids [159, 160] would include 
androcymbine-type intermediates, while a pathway from 
diaryl-3-azahexenoid-type precursors would by-pass these 
and directly produce dibenzo[d,f]azecines.  
CONCLUSION AND FURTHER STUDIES 
The raison d’être for alkaloids is still something of an 
enigma, and hypotheses have included views such as meta-
bolic waste or end products, as a source of stored nitrogen, 
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and as defense compounds or ecological adaptors [161, 162]. 
Regardless of the validity of any of these hypotheses, the 
large structural variation and the high proportion and wide 
range of biological activities associated with alkaloids make 
them a highly interesting compound-type for medicinal 
chemists. However, the research focus is often limited to a 
very small number of compounds with extraordinary activ-
ity, such as colchicine in the present example. This might be 
due to presence of low concentrations of minor components, 
bias in selection of screening assays for biological activity, 
or skewed sampling of plant material. We argue that by ac-
cepting the notion that natural products are prevalidated for 
biological activity and taking evolutionary aspects into ac-
count, these potential problems can be attenuated and open 
new avenues of interesting research.  
Of the phenethylisoquinoline alkaloids of Colchicaceae 
only colchicine-type alkaloids have been, and is still, exten-
sively investigated and the activity under scrutiny has almost 
exclusively been that of cytotoxicity. This leaves seven 
structural groups of alkaloids within the family for which we 
today have very little information on possible biological ac-
tivities and roles. Especially interesting from this perspective 
are the homoerythrinan alkaloids, seemingly absent in most 
of the family and replacing colchicine-type alkaloids in 
Tripladenieae. With the presence of these alkaloids in several 
distantly related plant groups it is imperative to predict that 
they have biological activities of potential for human use, 
and the reported molluscicidal and insecticidal activities can 
be considered as a starting point and need further investiga-
tions.  
From an evolutionary standpoint it is also obvious that 
the sampling of Colchicaceae has been very skewed. Almost 
70% of investigated species are from the genus Colchicum, 
and several genera lack in depth studies of their alkaloid con-
tent. This is notable for the early lineages as well as the sec-
ond most species rich genus Wurmbea. Compared to the 
structural diversity of known benzylisoquinoline and Ama-
ryllidaceae alkaloid types, which have at least analogous 
biosynthesis patterns, the phenethylisoquinoline alkaloids of 
Colchicaceae is a small group. This could be the result of 
undersampling of different phylogenetic lineages within the 
family.  
It has been argued that we only take advantage of a very 
small fraction of the plant biodiversity around us. As an ex-
ample De Luca and co-workers propose in depth collabora-
tive investigations of plant metabolomes, using new tech-
nologies to elucidate and modify biosynthetic pathways to 
create larger yields or new chemically diverse biological 
active compounds [163]. Another option for finding new 
compounds or activities, as argued here, is taking advantage 
of evolutionary evidence in selection of the plants or com-
pounds to be studied. The phylogenetic distribution of spe-
cific compounds predicts at least one of either presence of 
biosynthetic pathways or advantageous biological activity, 
thus identifying less known or unstudied chemistry. Based 
on the known phylogenetic hypothesis in Fig. (1) a number 
of hypotheses for further study can be identified, such as: the 
need to re-investigate Burchardia, including identification of 
the reported non-tropolonic alkaloid; perform studies on the 
presence or absence of alkaloids in the tribe Uvularieae, 
which at present is practically uninvestigated; an in depth 
study of the homoerythrinan alkaloids of the tribe 
Tripladenieae and their biological activities; and instigate 
molecular and biochemical comparison between species 
from Tripladenieae and Colchicaceae sensu stricto to inves-
tigate biosynthetic pathways. 
In conclusion we have shown how thinking about evolu-
tion can influence selection of plant material in drug lead 
discovery, and how knowledge about phylogenetic relation-
ships may be used to evaluate predicted biosynthetic path-
ways and identify priority species for further study. 
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